Vaginal stenosis and dilator use after pelvic brachytherapy

Introduction: To prevent vaginal stenosis, the use of a vaginal dilator is recommended. Objective: To analyze sociodemographic data, gynecological conditions and the use of vaginal dilator after pelvic brachytherapy. Materials and Methods: Cross-sectional, retrospective study, period 2016-2020, collected between October/2020 and February /2021, from records of women with gynecological cancer treated with brachytherapy at the Centro de Pesquisa Oncológicas (Brazil). The variables included sociodemographic data and gynecological conditions in following the treatment. In the analysis, descriptive statistics, chi-squaretest, Fisher's exact test and Mann-Whitney test were applied. Results: 519 patients records were included in the investigation; the analyzes showed significant associations between the topography and staging (p<0.001), education (p=0.004) and age (p<0.001); the comparison between the distribution of the ionizing radiation dose showed a difference with the continued sexual relationship category (p=0.006); the comparison between the proportions of continued sexual relationship and using a vaginal dilator was significant (p<0.001); 49.10% (131) adhered to the use of vaginal dilator; 24.50% (127) are not sexually active and do not adhere to the use of the dilator. Discussion: It is evident that social and gynecological conditions interfere with the presence of vaginal stenosis and the use of a vaginal dilator after pelvic brachytherapy. Conclusions: The adherence found in the use of dilator affirms the contributions and the need for health education by nurses and physicaltherapists during and following the treatment.

Research progress on the application of hydrogel spacer in brachytherapy for gynecological tumors / 中华放射肿瘤学杂志

Radiotherapy is an important treatment of gynecological tumors. Although novel techniques or measures in recemy years have improved the tumor control rate and reduced radiation toxicity, radiation toxicity remains a major problem due to the location of some key organs adjacent to the tumor. A new material-hydrogel, as an organ spacer, provides a new method to reduce the radiotherapy toxicity. In this article, the application of hydrogel as an organ spacer in brachytherapy for gynecological tumors was reviewed from the aspects of hydrogel characteristics, suitable population, mode of injection, interval distance and dose effect, clinical benefits and cost effectiveness, etc.

Effects of different doses of dexmedetomidine on inflammatory factors and immune function during laparoscopic surgery in patients with gynecological malignant tumors / 肿瘤研究与临床

Objective:To explore the effects of different doses of dexmedetomidine (DEX) on inflammatory factors and immune function in patients with gynecological malignant tumors who underwent laparoscopic surgery.Methods:A total of 60 patients with gynecological malignant tumors who underwent laparoscopic surgery from January 2021 to December 2021 in the Second Hospital of Shanxi Medical University were selected as the research objects. All patients were divided into the control group, low-dose DEX group (group D1) and high-dose DEX group (group D2) by using random number table method, 20 cases in each group. Patients in D1 and D2 groups were intravenously pumped DEX 0.5 μg/kg and 1.0 μg/kg 10 minutes before induction of anesthesia, and then maintained with DEX 0.5 μg·kg -1·h -1 and 1.0 μg·kg -1·h -1 until 30 minutes before the end of operation; and patients in the control group were given the same amount of Nacl solution. The 10 ml peripheral venous blood were collected at 10 minutes before induction of anesthesia (T 1), 1 h after pneumoperitoneum relief (T 2) and 24 h after pneumoperitoneum relief (T 3). The changes of interleukin-6 (IL-6), interleukin-10 (IL-10), the proportion of CD4 +, the proportion of CD8 + and CD4 +/CD8 + ratio of the three groups were compared, and the cases of bradycardia and hypotension in perioperative period and the time of first exhaust after operation were recorded. Results:At T 1,T 2 and T 3, the expression level of IL-6 in the control group was (7.95±0.26) pg/ml, (8.30±0.24) pg/ml and (8.35±0.28) pg/ml, respectively, and the difference was statistically significant ( F = 14.14, P < 0.001); the expression level of IL-10 in the control group was (38.9±2.6) pg/ml, (44.5±6.6) pg/ml and (46.3±4.6) pg/ml, respectively, and the difference was statistically significant ( F = 12.45, P < 0.001); the proportion of CD4 + in the control group was (38.5±2.1)%, (29.5±4.6)% and (29.6±3.5)%, respectively, and the difference was statistically significant ( F = 40.82, P < 0.001); the ratio of CD8 + in the control group was (30.1±3.7)%, (35.1±6.3)% and (40.3±8.2)%, respectively, and the difference was statistically significant ( F = 13.02, P < 0.001); the CD4 +/CD8 + ratio in the control group was 1.29±0.14, 0.84±0.09 and 0.75±0.14, respectively, and the difference was statistically significant ( F = 99.94, P < 0.001). The expression level of IL-6 in group D1 and group D2 was (8.10±0.32) pg/ml and (8.01±0.30) pg/ml at T 2, and (8.12±0.35) pg/ml and (8.05±0.34) pg/ml at T 3,which were lower than those in the control group, and the differences were statistically significant (all P < 0.05). The expression level of IL-10 in group D2 was (40.6±3.5) pg/ml at T 2, which was lower than that in the control group, and the difference was statistically significant ( P < 0.05). At T 3, the expression level of IL-10 in group D1 and group D2 was (43.7±3.5) pg/ml and (42.4±3.9) pg/ml, which were lower than those in the control group, and the differences were statistically significant (all P < 0.05). At T 2, the proportion of CD4 + in group D2 was (34.5±4.3)%, which was higher than that in the control group, and the difference was statistically significant ( P < 0.05). At T 3, the proportion of CD4 + in group D1 and group D2 was (32.1±4.2)% and (33.7±2.8)%, which were higher than those in the control group, and the differences were statistically significant (all P < 0.05). At T 2, the proportion of CD8 + in group D2 was (30.7±5.5)%, which was lower than that in the control group, and the difference was statistically significant ( P < 0.05). At T 3, the proportion of CD8 + in group D1 and group D2 was (35.4±5.8)% and (32.5±5.1)%, which were lower than those in the control group, and the differences were statistically significant (all P < 0.05). The CD4 +/CD8 + ratio in group D1 and D2 was 0.99±0.17 and 1.14±0.16 at T 2, 0.93±0.19 and 1.05±0.16 at T 3, which were higher than those in the control group, and the differences were statistically significant (all P < 0.05). Meanwhile, 1 case of hypotension occurred in the the control group and group D1, respectively; 3 cases of bradycardia and 2 cases of hypotension occurred in the group D2. The time of exhaust in the control group was later than that in group D1 and D2, and the difference was statistically significant ( P < 0.05). Conclusions:DEX can inhibit the inflammatory reaction during laparoscopic surgery in patients with gynecological malignant tumors, reduce immune damage. The anti-inflammatory action and immune protection of high-dose of DEX is more significant compared with low-dose of DEX, while high dose of DEX is more likely to cause hemodynamic fluctuations in perioperative period.

Development of couples′ communication quality scale for gynecological cancer patients and its reliability and validity / 中国实用护理杂志

Objective:To develop couples′ communication quality scale for gynecological cancer patients and test its reliability and validity in accordance with Chinese cultural background.Methods:The scale was initially formed by literature review and Delphi expert consultation. From May to November in 2021, the scale was initially formed by literature review and Delphi expert consultation. A cross-sectional survey of 360 gynecologic cancer patients in Qilu Hospital, Shandong University was conducted from May to August 2021 using a convenience sampling method, and after pretesting, item analysis and exploratory factor analysis were used to screen the scale items. After the formal scale was formed, 385 gynecological cancer patients from Qilu Hospital, Shandong University were conveniently selected for formal testing from September to November 2021, and the reliability and validity of the scale was tested.Results:The formal couples′ communication quality scale for gynecological cancer patients was composed of 34 items from 5 dimensions of "self-disclosure", "perceived response", "stress coping", "normal creation" and "constructive action", with a cumulative variance contribution rate of 68.181%. The Cronbach α coefficient of the scale was 0.949, the split-half reliability coefficient was 0.766, the retest reliability coefficient was 0.898, and the criterion validity coefficient was 0.696. The model′s χ2/ df was 1.778, root mean square error of approximation was 0.047, comparative fit index was 0.956, incremental fix index was 0.956, Tucker-Lewis index was 0.952, normal of fit index was 0.905. Conclusions:The scale can be used to evaluate the quality of couples′ communication among gynecological cancer patients in Chinese context with good reliability and validity.

Knowledge about human papillomavirus transmission and prevention among physicians in Rio de Janeiro state, Brazil

SUMMARY OBJECTIVE: This study aimed to assess physicians' knowledge about human papillomavirus infection and its prevention. METHODS: Descriptive web-based survey with 15 objective questions targeted to physicians affiliated with the Regional Council of Medicine from Rio de Janeiro state, Brazil. Participants were invited by e-mail and the Council social networks, between January and December 2019. RESULTS: The study sample had 623 participants, with a median age of 45 years, predominantly women (63%). The most frequent specialties were Obstetrics and Gynecology (21.1%), Pediatrics (11.2%), and Internists (10.5%). Concerning human papillomavirus knowledge, 27.9% of the participants were able to identify accurately all possible forms of transmission, and none of them could recognize all the risk factors of infection. Nevertheless, 95% recognized that asymptomatic infection could occur in both sexes. Regarding knowledge about clinical manifestations, diagnosis, and screening, only 46.5% were able to identify all human papillomavirus-related cancers, 42.6% were aware of the periodicity of Pap smears, and 39.4% indicated that serological test was not adequate for diagnosis. The recommended age group for human papillomavirus vaccination was recognized by 94% of the participants, as well as the need for a Pap smear and the use of condoms, even after vaccination. CONCLUSIONS: There is good knowledge about prevention and screening for human papillomavirus infections; many gaps were identified regarding transmission, risk factors, and associated diseases among physicians in Rio de Janeiro state.

Validity study of educational technology on gynecological high dose rate (HDR) brachytherapy / Estudio de validación de tecnología educativa sobre braquiterapia ginecológica de alta tasa de dosis (HDR) / Estudo de validação de tecnologia educativa sobre braquiterapia ginecológica de alta taxa de dose (HDR)

ABSTRACT Objective: to construct and validate an educational booklet on high dose rate gynecological brachytherapy (HDR) for women with gynecologic cancer. Methods: a methodological study, with the construction and validity of a booklet based on the Doak, Doak and Root theoretical-methodological framework. Content and appearance validity was guided by the Delphi technique, by 11 judges, selected using Jasper's criteria. Afterwards, clinical validity was carried out with the target population. Results: the booklet, built from evidence from an integrative review, validated with judges, obtained an overall CVI of 0.98. After clinical validity with 27 women, it presents 24 sheets with illustrations produced by a graphic designer, subdivided into topics: gynecological system anatomy and gynecological cancer epidemiology, gynecological brachytherapy definition, therapeutic steps, approach to side effects and management, and two pages for notes. Conclusions: the booklet has validity for use in HDR gynecological brachytherapy treatment.

RESUMEN Objetivo: construir y validar un folleto educativo sobre braquiterapia ginecológica de alta tasa de dosis (radiación de alta dosis-HDR) para mujeres con cáncer ginecológico. Métodos: estudio metodológico, con la construcción y validación de un cuadernillo basado en el marco teórico-metodológico de Doak, Doak y Root. La validación de contenido y apariencia fue guiada por la técnica Delphi, por 11 jueces, seleccionados según los criterios de Jasper. Posteriormente se realizó la validación clínica con la población diana. Resultados: la cartilla, construida a partir de evidencias de revisión integradora, validada con jueces, obtuvo un IVC global de 0,98. Después de la validación clínica con 27 mujeres, presenta 24 fichas, con ilustraciones realizadas por un diseñador gráfico, subdivididas en temas: anatomía del sistema ginecológico y epidemiología de los cánceres ginecológicos, definición de braquiterapia ginecológica, pasos terapéuticos, abordaje de los efectos secundarios y manejo, y dos páginas para notas. Conclusiones: la cartilla tiene validación para su uso en el tratamiento de braquiterapia ginecológica de la HDR.

RESUMO Objetivo: construir e validar uma cartilha educativa sobre braquiterapia ginecológica de alta taxa de dose (high dose radiation-HDR) para mulheres com câncer ginecológico. Métodos: estudo metodológico, com construção e validação de uma cartilha embasada no referencial teórico-metodológico de Doak, Doak e Root. A validação de conteúdo e aparência norteou-se pela técnica Delphi, por 11 juízes, selecionados através dos critérios de Jasper. Após, realizou-se a validação clínica com a população-alvo. Resultados: a cartilha, construída a partir de evidências de uma revisão integrativa, validada com juízes, obteve IVC global de 0,98. Após validação clínica com 27 mulheres, apresenta 24 folhas, com ilustrações produzidas por designer gráfico, subdividida em tópicos: anatomia do sistema ginecológico e epidemiologia dos cânceres ginecológicos, definição de braquiterapia ginecológica, etapas terapêuticas, abordagem dos efeitos colaterais e manejo, e duas páginas destinadas para anotações. Conclusões: a cartilha possui validação para uso no tratamento de braquiterapia ginecológica de HDR.

Significado do uso da prótese peniana de silicone no seguimento da braquiterapia pélvica / Significado do uso da prótese peniana de silicone no seguimento da braquiterapia pélvica / Meaning of the use of silicone penile prosthesis in the follow-up of pelvic brachytherapy

Objetivo: descrever o significado do uso da prótese peniana de silicone para dilatação vaginal no seguimento da braquiterapia em mulheres com câncer ginecológico. Método: pesquisa narrativa, realizada no Centro de Pesquisas Oncológicas, Brasil, com 34 mulheres, após braquiterapia pélvica, em seguimento no serviço de fisioterapia. Coleta de dados por entrevistas semiestruturadas, incluindo dados sociodemográficos, clínicos e o significado do uso da prótese peniana na dilatação vaginal, submetidas à análise de conteúdo e discutidas à luz do estudo From 'sex toy' to intrusive imposition. Resultados: o significado perpassa o exercício de dilatação vaginal; as dificuldades relacionadas às condições vaginais, doença, tratamento, dor, sexo, constrangimentos, preconceitos, falhas na educação em saúde; as motivações relacionam-se à busca por qualidade de vida, apoio dos companheiros e profissionais. Conclusão: a abordagem de possíveis barreiras emocionais, psicológicas, sociais e físicas deve ser planejada e executada para prevenção da estenose vaginal e melhor acolhimento.

Objective: to describe the meaning of the use of silicone penile prosthesis for vaginal dilation in the follow-up of brachytherapy in women with gynecological cancer. Method: narrative research conducted at the Centro de Pesquisas Oncológicas, Brazil, with 34 women after pelvic brachytherapy, under follow-up at the physical therapy service. Data collection through semi-structured interviews, including sociodemographic and clinical data and the significance of the use of penile prosthesis in vaginal dilation, submitted to content analysis and discussed in the light of the study From 'sex toy' to intrusive imposition. Results: the meaning permeates the vaginal dilation exercise; difficulties related to vaginal conditions, disease, treatment, pain, sex, constraints, prejudices, failures in health education; motivations are related to the search for quality of life, support of partners and professionals. Conclusion: the approach of possible emotional, psychological, social and physical barriers should be planned and executed for prevention of vaginal stenosis and better reception.

Objetivo: describir el significado del uso de una prótesis peneana de silicona para la dilatación vaginal posterior a la braquiterapia en mujeres con cáncer ginecológico. Método: investigación narrativa, realizada en el Centro de Pesquisas Oncológicas, Brasil, con 34 mujeres, después de braquiterapia pélvica, en seguimiento en el servicio de fisioterapia. Recopilación de datos a través de entrevistas semiestructuradas, incluyendo datos sociodemográficos y clínicos y el significado del uso de prótesis peneana en la dilatación vaginal, sometidos a análisis de contenido y discutidos a la luz del estudio From 'sex toy' to intrusive imposition. Resultados: el significado impregna el ejercicio de dilatación vaginal; dificultades relacionadas con condiciones vaginales, enfermedad, tratamiento, dolor, sexo, vergüenza, prejuicios, fallas en la educación para la salud; las motivaciones están relacionadas con la búsqueda de calidad de vida, apoyo de la pareja y profesionales. Conclusión: se debe planificar y ejecutar el abordaje de las posibles barreras emocionales, psicológicas, sociales y físicas para prevenir la estenosis vaginal y una mejor recepción.

Câncer que toma o corpo feminino: representações dialogadas / Cancer that takes the female body: dialogic representations / Cáncer que toma el cuerpo femenino: representaciones dialógicas

Objetivo: descrever os conteúdos representacionais de mulheres vivenciando o câncer feminino. Método: estudo descritivo, exploratório e qualitativo, realizado com 20 mulheres em um centro de oncologia. Os dados foram coletados por entrevistas semiestruturadas áudio-gravadas, transcritas na íntegra, analisadas de acordo com a análise de conteúdo de Bardin. Utilizou-se como referencial teórico a Teoria das Representações Sociais. Resultados: da análise, emergiram quatro categorias que traduziram os conteúdos representacionais das mulheres, permeados pelo sofrimento interno e ancorados em representações de morte e medo. As falas apontaram que a depressão se une à essas representações, refletindo nas tomadas de decisões. O apoio social e forma como a mulher recebe o diagnóstico tem influência decisiva nas representações construídas e tratamento. Conclusão: dentro das representações sociais que cada mulher apresenta existem significados que requerem um olhar minucioso para se prestar uma assistência individualizada e que compreenda os processos biopsicossociais vivenciados pela mulher enfrentando o câncer.

Objective: to describe the representational contents of women experiencing female cancer. Method: in this exploratory, qualitative, descriptive study of 20 women in an oncology center, data were collected through audio-recorded, semi-structured, fully transcribed interviews and analyzed using Bardin content analysis. Social Representations Theory was used as a theoretical framework. Results: from the analysis, four categories emerged that expressed the representational contents voiced by the women, which were permeated by inner suffering and anchored in representations of death and fear. Their words showed that depression is linked to these representations and reflects on decision-making. Social support and how women receive their diagnosis have decisive influence on the representations constructed and on treatment. Conclusion: within the social representations that each woman presented, were meanings that required thorough consideration in order to provide individualized care that contemplated the biopsychosocial processes experienced by women facing cancer.

Objetivo: describir los contenidos representativos de mujeres que padecen cáncer femenino. Método: estudio descriptivo, exploratorio y cualitativo, realizado junto a 20 mujeres en una unidad oncológica. Se recolectaron los datos fueron a través de entrevistas semiestructuradas grabadas en audio, transcritas en su totalidad, analizadas según el análisis de contenido de Bardin. Se utilizó la Teoría de las Representaciones Sociales como marco teórico. Resultados: del análisis surgieron cuatro categorías que tradujeron los contenidos representacionales de las mujeres, impregnados por el sufrimiento interno y anclados en representaciones de muerte y miedo. Las declaraciones mostraron que la depresión se une a estas representaciones, reflejándose en la toma de decisiones. El apoyo social y la forma cómo la mujer recibe el diagnóstico tiene influencia en las representaciones y el tratamiento. Conclusión: dentro de las representaciones que presenta cada mujer, existen significados que requieren una mirada profunda para brindar una atención individualizada que comprenda los procesos biopsicosociales que viven las mujeres frente al cáncer.

Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors / 中华妇产科杂志

Objective:To investigate the clinicopathological features, diagnosis, treatment and prognosis of simultaneous double primary gynecological malignant tumors.Methods:A total of 23 patients with simultaneous double primary malignant tumors of female reproductive system primarily treated in Beijing Obstetrics and Gynecology Hospital, Capital Medical University from January 1, 2010 to December 31, 2020 were retrospectively collected. The age, symptoms, tumor stage, tumor type, treatment and prognosis of patients were collected and followed up.Results:(1) The number of patients with gynecological tumors in our hospital increased year by year in the past 11 years. A total of 8 987 patients with gynecological malignant tumors were firstly diagnosed and cured in our hospital, including 3 474 cases of cervical cancer, 3 484 cases of endometrial cancer, 1 329 cases of ovarian malignancies, 171 cases of fallopian tube cancer, 182 cases of uterine sarcoma, 42 cases of vaginal cancer, 192 cases of vulvar cancer, 110 cases of trophoblastic tumor and 3 cases of other gynecological malignancies. The top three cancers were endometrial cancer, cervical cancer and ovarian malignancies. (2) There were 23 patients identified with simultaneous double primary gynecological tumors in the past 11 years, accounting for 0.26% (23/8 987) of female malignant tumors. There were 3 cases of cervical cancer complicated with endometrial cancer, 3 cases of cervical cancer complicated with ovarian cancer, 16 cases of endometrial cancer combined with ovarian cancer, and 1 patient with endometrial cancer combined with fallopian tube cancer. (3) All 23 patients underwent surgical treatment. According to the first diagnosis of the tumor, the surgical methods included cervical cancer radical surgery, endometrial cancer staging surgery and ovarian cancer cytoreductive surgery. After operation, radiotherapy and chemotherapy were supplemented according to the results of pathological examination and tumor staging. (4) The age of 23 patients ranged from 28 to 66 years, with an average age of (49.4±9.7) years. All patients had vaginal bleeding or conscious pelvic mass as their main clinical manifestation. The clinical stage was found in 7 patients (30%, 7/23) with advanced gynecological cancer (stage Ⅲ-Ⅳ), and 16 patients (70%, 16/23) with early stage gynecological cancer (stage Ⅰ-Ⅱ). According to the nonspecific tumor markers, 13 patients (57%, 13/23) had elevated CA 125 and CA 199. (5) Among the 23 patients, 1 case was uncontrolled and 3 cases recurred during the follow-up period, and the sites of uncontrolled or recurred were all located in the abdominopelvic cavity. Three cases died. Among the 3 patients who died, 1 patient was an uncontrolled patient, whose tumor type was cervical adenosquamous cell carcinoma combined with ovarian clear cell adenocarcinoma. The overall survival time was 19 months with postoperative supplementary radiotherapy and chemotherapy. There were 2 recurrent patients, and the tumor types were endometrioid carcinoma complicated with high-grade serous ovarian carcinoma and ovarian endometrioid carcinoma, respectively. After surgery, all patients received supplementary chemotherapy and recurred 60 and 21 months after surgery, respectively, and the overall survival time was 78 and 28 months, respectively. Another patient recurred 43 months after surgery, and survived with tumor for 14 months after recurrence. The remaining 19 patients were tumor-free and were still being followed up. Conclusions:There are no specific markers for simultaneous double primary gynecological malignant tumors. The most common clinical symptoms are vaginal bleeding or pelvic mass. The treatment principle of simultaneous double primary gynecological malignant tumor is the same as that of single gynecological malignant tumor, but need to be taken into account the characteristics of two tumors. Surgery is the main treatment method, and radiotherapy and chemotherapy play an important auxiliary role. The prognosis of simultaneous double primary gynecological malignancies is related to the late stage of the two malignancies.

The role of energy devices in reducing the complications of gynecological tumor surgery / 中国医师杂志

Energy devices have been widely used in gynecological surgeries. From the overall development trend, energy devices improve the efficiency of surgery. The continuous updating and upgrading of energy devices also reduces surgical complications and improves the safety of surgery. The injury caused by energy devices is not only related to the complexity of the operation or the disease itself, but also closely related to whether the operator can reasonably choose and master the use of energy instruments, as well as the surgical skills and experience of the operator. Surgeons should establish the concept of " prevention is better than remedy" when using energy instruments. We should take the initiative to learn and master the working principle of different energy devices, understand the design characteristics of each product and improve the skills of device use, so as to minimize the complications caused by various energy instruments and bring real benefits to doctors and patients.

Vascular injury and treatment in gynecological tumor surgery / 中国医师杂志

During gynecological tumor surgery, the incidence of iatrogenic vascular injury increases unabated due to the proximity of the operative area to important vessels in the pelvic and abdominal cavity, and the tumor growth is invasive and often adheres or oppresses the surrounding blood vessels. Intraoperative bleeding is related to many factors. Adequate preoperative evaluation, surgical field exposure, and skilled operation can effectively reduce intraoperative vascular injuries. Immediate recognition and prompt action at the occurrence of hemorrhage can significantly minimize life-threatening complications. This article reviews the common vascular injuries and treatment methods in gynecological tumor surgery.

Progress of pyroptosis in gynecological diseases / 肿瘤研究与临床

Pyroptosis is a fairly new type of cell death that is frequently mediated by inflammasomes and is strongly related to Gasdermin protein family and cysteinyl aspartate specific proteinase (caspase). The importance of pyroptosis-related molecules in the occurrence and progression of gynecological diseases cannot be overstated. This article reviews the related mechanism of cell pyroptosis, and the relationship between pyroptosis and benign and malignant gynecological diseases, so as to provide references for the research of the diagnosis and treatment of gynecological diseases, as well as the development of targeted drugs.

Efficacy observation of interstitial brachytherapy in locally recurrent and metastatic advanced gynecologic cancer / 肿瘤研究与临床

Objective:To evaluate the efficacy and safety of interstitial brachytherapy for locally recurrent and metastatic advanced gynecologic tumors.Methods:The data of patients with local recurrence and metastasis of advanced gynecological tumors who underwent brachytherapy in Shanxi Province Cancer Hospital from June 2020 to July 2021 were retrospectively analyzed. Objective remission rate (ORR) was compared among patients grouped according to the size, location of the lesion, and progression-free survival (PFS) before recurrence. Kaplan-Meier method was used to analyze the PFS after recurrence and group comparison was performed by using log-rank (Mantal-Cox) test. Multivariate Cox proportional hazard model was used to analyze the influencing factors of PFS after recurrence. The acute and advanced radiation injuries were also summarized.Results:A total of 20 patients were enrolled and the whole ORR was 80% (16/20). Subgroup analysis showed that 13 patients with focal length < 4 cm had objective remission, and 3 patients with focal length ≥ 4 cm had objective remission; the difference in ORR between the two groups was statistically significant ( P = 0.007). And 3 cases out of 6 cases with PFS time less than 6 months before recurrence and 13 cases out of 14 cases with PFS time equal to or more than 6 months before recurrence all had objective remission, and the difference was statistically significant ( P = 0.061). The median follow-up time was 6 months (1-13 months). By the end of follow-up, 9 patients (45%) had disease progression. Univariate survival analysis showed that patients with focal length < 4 cm (≥ 4 cm vs. < 4 cm: HR = 4.192, 95% CI 0.992-17.710, P = 0.029), PFS time before recurrence ≥ 6 months (≥ 6 months vs. < 6 months: HR = 0.163, 95% CI 0.038-0.696, P = 0.004), and radiation dose ≥ 15 Gy (≥ 15 Gy vs. < 15 Gy: HR = 0.207, 95% CI 0.049-0.881, P = 0.016) had better PFS after recurrence, but multivariate Cox regression analysis showed that the above factors were not independent factors of PFS after recurrence (all P > 0.05). None of 20 patients had radiation injury of rectum and bladder above grade 3. Conclusion:The therapeutic effect of interstitial brachytherapy for local recurrence and metastasis of advanced gynecological tumors is clear and safe.

Clinical application of 99Tc m-sulfur colloid lymphoscintigraphy in the diagnosis of lower limb lymphedema after gynecological tumor surgery / 肿瘤研究与临床

Objective:To explore the significance of 99Tc m-sulfur colloid lymphoscintigraphy in the diagnosis of lower limb lymphedema after gynecological tumor surgery. Methods:The clinical data of patients with lower limb lymphedema after gynecological tumor surgery in Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology from May 2015 to October 2019 were retrospectively analyzed. 99Tc m-sulfur colloid lymphoscintigraphy was performed in all patients. The results of lymphatic vessel imaging, lymph node imaging and their combination in the diagnosis of lower limb lymphedema were analyzed. The diagnostic efficacy of lymphatic vessel imaging alone, lymph node imaging alone and their combination was evaluated by the receiver operating characteristic (ROC) curve and the area under the curve (AUC), and the Youden index, sensitivity and specificity were calculated. Results:Among the 100 lower limbs of 50 patients, 56 limbs had lymphedema and 44 limbs had no obvious edema. When diagnosis was based on abnormal lymphatic vessel imaging alone, among 56 lower limbs with lymphedema, lower limbs lymphatic vessel imaging was positive in 38 (67.9%) and negative in 18 (32.1%); among 44 lower limbs without obvious edema, lower limbs lymphatic vessel imaging was positive in 6 (13.6%) and negative in 38 (86.4%); the sensitivity was 67.9%, the specificity was 86.4%, and the Youden index was 0.543. When diagnosis was based on abnormal lymph node imaging alone, among 56 lower limbs with lymphedema, lower limbs lymph node imaging was positive in 42 (75.0%) and negative in 14 (25.0%); among 44 lower limbs without obvious edema, lower limbs lymph node imaging was positive in 13 (29.5%) and negative in 31 (70.5%); the sensitivity was 75.0%, the specificity was 70.5%, and the Youden index was 0.455. When diagnosis was based on the combination of lymphatic vessel imaging and lymph node imaging, among 56 lower limbs with lymphedema, lymphatic vessel imaging and lymph node imaging were positive in 48 (85.7%) and negative in 8 (14.3%); among 44 lower limbs without obvious edema, lymphatic vessel imaging and lymph node imaging were positive in 14 (31.8%) and negative in 30 (68.2%); the sensitivity was 85.7%, the specificity was 68.2%, and the Youden index was 0.539. The AUC for the combined diagnosis of lymphatic vessel imaging and lymph node imaging was 0.781, the AUC for the diagnosis of abnormal lymphatic vessel imaging was 0.771, and the AUC for the diagnosis of abnormal lymph node imaging was 0.739 (all P < 0.01). Conclusions:99Tc m-sulfur colloid lymphoscintigraphy is of great help in the diagnosis of lower limb lymphedema after operation of gynecological tumors. The combination of lymph node imaging and lymphatic vessel imaging is more effective in the diagnosis of lower limb lymphedema.

Effect of chronic comorbidities on quality of life of gynecologic cancer patients in Puerto Rico / Efecto de las comorbilidades crónicas sobre la calidad de vida de pacientes con cáncer ginecológico en Puerto Rico / Efeito das comorbidades crônicas na qualidade de vida de pacientes com câncer ginecológico em Porto Rico

ABSTRACT Objective. To describe prevalence of chronic diseases and evaluate associations between comorbidities and quality of life in gynecologic cancer patients in Puerto Rico. Methods. A cross-sectional study among 233 women aged ≥21 years with a gynecologic cancer diagnosis. Through telephone interviews, information on comorbidities, quality of life, and other covariates were assessed. Quality of life included six items, assessing physical and mental health. Multivariate logistic regression models were used to estimate magnitude of association between the comorbidities under study (diabetes, cardiovascular and autoimmune diseases) and quality-of-life items, through adjusted prevalence odds ratio (aPOR; 95% confidence interval [CI]). Results. Most women (90.1%) reported one or more comorbidities in addition to their cancer diagnosis; cardiovascular diseases (63.1%) were more common than autoimmune diseases (37.3%) and diabetes (33.9%). Between 30% and 40% of the sample indicated dysfunctions in their general health (39.5%) and frequent physical (33.9%) and mental distress (31.8%). Adjusting for age and gross family income, women with autoimmune diseases presented higher prevalence of frequent limitations for daily activities (aPOR 2.00; 95% CI 1.05-3.81), poor general health (aPOR 3.52; 95% CI 1.90-6.49), frequent mental distress (aPOR 2.19; 95% CI 1.19-4.03), and dissatisfaction with life (aPOR 4.86; 95% CI 1.82-12.95) compared to those who did not report autoimmune diseases. No associations with cardiovascular diseases and diabetes were observed. Conclusions. Quality-of-life dysfunctions were highly prevalent in this population of gynecologic cancer patients. Suffering from autoimmune comorbidities significantly exacerbated those dysfunctions.

RESUMEN Objetivo. Describir la prevalencia de enfermedades crónicas y evaluar la asociación entre varias comorbilidades y la calidad de vida de pacientes con cáncer ginecológico en Puerto Rico. Métodos. Se llevó a cabo un estudio transversal con 233 mujeres de 21 años o más con diagnóstico de cáncer ginecológico. Mediante entrevistas telefónicas se evaluó la información sobre comorbilidades, calidad de vida y otras covariantes; para la calidad de vida, se evaluaron seis elementos relativos a la salud física y mental. Se emplearon modelos de regresión logística con múltiples variables para estimar la magnitud de la asociación entre las comorbilidades objeto de estudio (la diabetes, las enfermedades cardiovasculares y las enfermedades autoinmunitarias) y los elementos relativos a la calidad de vida, mediante una razón de posibilidades de prevalencia ajustada (RPPa; intervalo de confianza [IC] de 95 %). Resultados. La mayoría de las mujeres (90,1 %) notificaron una o más comorbilidades además del diagnóstico de cáncer; las enfermedades cardiovasculares (63,1 %) fueron más comunes que las enfermedades autoinmunitarias (37,3 %) y la diabetes (33,9 %). Entre 30 % y 40 % de la muestra refirió disfunciones generales de salud (39,5 %) y malestar físico (33,9 %) y mental (31,8 %) frecuente. Luego de ajustar por edad e ingresos brutos familiares, las mujeres con enfermedades autoinmunitarias presentaron una mayor prevalencia de limitaciones frecuentes en las actividades cotidianas (RPPa 2,00; IC de 95 % 1,05-3,81), mala salud general (RPPa 3,52; IC de 95 % 1,90-6,49), angustia frecuente (RPPa 2,19; IC de 95 % 1,19-4,03) e insatisfacción vital (RPPa 4,86; IC de 95 % 1,82-12,95), en comparación con las mujeres que no refirieron ninguna enfermedad autoinmunitaria. No se observó ninguna asociación con enfermedades cardiovasculares o la diabetes. Conclusiones. Las disfunciones relativas a la calidad de vida tuvieron una alta prevalencia en esta población de pacientes con cáncer ginecológico. Sufrir comorbilidades autoinmunitarias agravó significativamente estas disfunciones.

RESUMO Objetivo. Descrever a prevalência de doenças crônicas e avaliar as associações entre comorbidades e qualidade de vida em pacientes com câncer ginecológico em Porto Rico. Métodos. Estudo transversal de 233 mulheres com idade ≥21 anos, com diagnóstico de câncer ginecológico. Mediante entrevistas telefônicas, foram avaliadas informações sobre comorbidades, qualidade de vida e outras covariáveis. A avaliação da qualidade de vida incluiu seis itens, abrangendo saúde física e mental. Foram utilizados modelos de regressão logística multivariada para estimar a magnitude da associação entre as comorbidades avaliadas (diabetes, doenças cardiovasculares e autoimunes) e os itens de qualidade de vida, por meio da razão de chances de prevalência ajustada (aPOR) com intervalo de confiança de 95% (IC 95%). Resultados. A maioria das mulheres (90,1%) relatou uma ou mais comorbidades além de seu diagnóstico de câncer; as doenças cardiovasculares (63,1%) foram mais comuns que as doenças autoimunes (37,3%) e diabetes (33,9%). Entre 30% e 40% das entrevistadas relataram problemas de saúde geral (39,5%) e frequentes problemas físicos (33,9%) e mentais (31,8%). Após ajuste para idade e renda familiar bruta, as mulheres com doenças autoimunes apresentaram maior prevalência de limitação frequente das atividades da vida diária (aPOR 2,00; IC 95% 1,05-3,81), saúde geral precária (aPOR 3,52; IC 95% 1,90-6,49), angústia mental frequente (aPOR 2,19; IC 95% 1,19-4,03) e insatisfação com a vida (aPOR 4,86; IC 95% 1,82-12,95), em comparação àquelas que não relataram doenças autoimunes. Não foram observadas associações com doenças cardiovasculares ou diabetes. Conclusões. Foi constatada uma prevalência elevada de disfunções de qualidade de vida nesta população de pacientes com câncer ginecológico. Sofrer de comorbidades autoimunes exacerbou significativamente essas disfunções.

Las enzimas metalo-óxidorreductasas: posibles biomarcadores de tumores ginecológicos

RESUMEN La incidencia de tumores epiteliales ginecológicos y su diagnóstico en etapas avanzadas ocasionan daños físicos, impactan en la salud reproductiva y producen afectaciones psicológicas en las mujeres. Reducir el tiempo de su detección constituye un gran reto para la Salud Pública. El conocimiento y validación de diversos métodos enzimáticos de estudio, aplicados a la patología tumoral, permitirá la integración de cada resultado al entramado de reacciones, mecanismos de reconocimiento molecular y celular, así como de las vías de señalización, útiles para la comprensión de la enfermedad y sus mecanismos diagnósticos y terapéuticos. La determinación de la actividad de las enzimas metalo-óxidorreductasas en suero es una tentativa para la implementación de biomarcadores líquidos para el diagnóstico temprano y el pronóstico de tumores ginecológicos. El objetivo del presente trabajo es la recopilación de información actualizada acerca de los biomarcadores enzimáticos para la predicción, diagnóstico y seguimiento de los tumores epiteliales ginecológicos.

ABSTRACT The incidence of gynecological epithelial tumors and their diagnosis in advanced stages cause physical damage, impact on reproductive health and produce psychological effects in women. Reducing the time of its detection constitutes a great challenge for public health. The knowledge and validation of various enzymatic study methods, applied to tumor pathology, will allow the integration of each result into the network of reactions, molecular and cellular recognition mechanisms, as well as signaling pathways, useful for understanding the disease and its diagnostic and therapeutic mechanisms. The determination of the activity of metallo-oxidoreductases enzymes in serum is an attempt to implement liquid biomarkers for the early diagnosis and prognosis of gynecological tumors. The aim of the research is the compilation of updated information about enzyme biomarkers for the prediction, diagnosis and follow-up of gynecological epithelial tumors.

Effects of different doses of dexmedetomidine on levels of serum claudin-1 and diamine oxidase in patients undergoing laparoscopic radical resection of gynecological malignant tumors / 肿瘤研究与临床

Objective:To explore the effect of different doses of dexmedetomidine (Dex) on levels of tight-junction protein claudin-1 and diamine oxidase (DAO) in patients undergoing laparoscopic radical resection of gynecological malignant tumors.Methods:A total of 60 patients with gynecological malignant tumors who were scheduled to undergo laparoscopic radical resection under general anesthesia from January 2019 to January 2020 in the Second Hospital of Shanxi Medical University were selected, including 43 cases of cervical cancer (stageⅠ-Ⅱ A), 9 cases of ovarian cancer (stageⅠ A-Ⅲ C), and 8 cases of endometrial carcinoma (stageⅠ). Accroding to the random number table method, the patients were divided into control group (group C), low-dose Dex group (group D 1) and high-dose Dex group (group D 2), with 20 cases in each group. Patients in group D 1 were given Dex 0.5 μg·kg -1·h -1 by constant rate intravenous infusion pump after induction until 30 min before the end of operation. Patients in group D 2 were given Dex 1.0 μg·kg -1·h -1 by constant rate intravenous infusion pump after induction until 30 min before the end of operation. Group C adopted the same calculation method and received the same amount of 0.9% sodium chloride solution by infusion pump. At 10 min before induction (T 1), 1 hour after pneumoperitoneum (T 2) and 12 hours after pneumoperitoneum (T 3), 5 ml of brachial vein blood was collected from the patients, and the levels of claudin-1 protein, DAO and blood glucose were measured. Results:At T 1, T 2 and T 3, the expression levels of claudin-1 in group C were (77.05±17.61) pg/ml, (66.76±12.97) pg/ml and (55.93±12.71) pg/ml, and the difference was statistically significant ( F = 10.449, P<0.05); the expression levels of DAO in group C were (4.83±0.93) ng/ml, (5.62±1.01) ng/ml and (5.98±1.21) ng/ml, and the difference was statistically significant ( F = 6.139, P < 0.05); the levels of blood glucose in group C were (4.82±0.66) mmol/L, (7.55±0.94) mmol/L and (6.51±0.54) mmol/L, and the difference was statistically significant ( F = 70.197, P < 0.05). At T 2, the expression level of claudin-1 in group D 1 was (69.12±13.02) pg/ml, which was not significantly different from group C ( t = -0.575, P > 0.05); the expression level of claudin-1 in group D 2 was (76.36±14.89) pg/ml, which was higher than that in group C, and the difference was statistically significant ( t = -2.175, P < 0.05). At T 3, the expression levels of claudin-1 in group D 1 and group D 2 were (66.14±14.36) pg/ml and (73.37±16.93) pg/ml, which were higher than that in group C, and the differences were statistically significant ( t values were -2.380 and -3.682, both P < 0.05). The expression levels of DAO in group D 1 and group D 2 were (5.02±0.84) ng/ml and (4.91±0.93) ng/ml at T 2, and (5.29±0.86) ng/ml and (5.20±0.98) ng/ml at T 3, which were lower than those in group C, and the differences were statistically significant ( t values were 2.051, 2.295, 2.079 and 2.285, all P < 0.05). The levels of blood glucose in group D 1 and group D 2 were (7.10±0.66) mmol/L and (6.77±0.97) mmol/L at T 2, and (5.95±0.94) mmol/L and (5.93±0.74) mmol/L at T 3, which were lower than those in group C, and the differences were statistically significant ( t values were 2.565, 5.374, 2.293 and 2.765, all P < 0.05). Conclusion:Continuous infusion of Dex can inhibit the stress response caused by long-term CO 2 pneumoperitoneum in laparoscopic radical resection of gynecological malignant tumors, and adjust the changes of expression levels of claudin-1 protein and DAO, reduce the damage of intestinal mucosal cells, facilitate the recovery of intestinal function, and the effect of high-dose Dex is better than low-dose Dex.

Estenose vaginal pós-braquiterapia: ocorrências e repercussões em mulheres com câncer ginecológico / Estenosis después de la braquiterapia vaginal: ocurrencias y repercusiones en las mujeres con cáncer ginecológico / Post-brachytherapy vaginal stenosis: occurrences and repercussions in women with gynecological cancer

RESUMO Objetivo: identificar a ocorrência da estenose vaginal pós-braquiterapia ginecológica e suas repercussões na perspectiva das mulheres. Método: estudo quanti-qualitativo, com desenho comparativo com corte longitudinal, envolvendo 23 mulheres; e com desenho interpretativo envolvendo sete mulheres, sustentado pelo referencial teórico da cultura. Ambos realizados em um serviço de radioterapia oncológica no sul do Brasil. A coleta dos dados foi realizada em 2019, sendo submetidos à estatística descritiva e análise temática. Resultados: constatou-se que 22 das participantes apresentaram estenose vaginal em algum momento da avaliação, sendo o grau 1 mais incidente. Das repercussões, identificou-se o sofrimento durante a prática sexual e a falta de compreensão do parceiro. Conclusão: a estenose vaginal repercute além da fisiologia da mulher, implicando em aspectos físicos e emocionais. Logo, esta pesquisa fornece subsídios para a tomada de decisões de enfermeiros, profissionais de saúde e gestores para intervir nas repercussões da estenose vaginal pós-braquiterapia ginecológica.

RESUMEN Objetivo: identificar la ocurrencia de la estenosis vaginal post-braquiterapia ginecológica y sus repercusiones en la perspectiva de las mujeres. Método: estudio cuanti-cualitativo, con diseño comparativo con corte longitudinal, envolviendo a 23 mujeres; y con diseño interpretativo envolviendo a siete mujeres, sustentado en el referente teórico de la cultura. Ambos realizados en un servicio de oncología radioterápica del sur de Brasil. La recogida de datos se realizó en 2019, siendo sometida a estadística descriptiva y análisis temático. Resultados: se encontró que 23 de las participantes presentaron estenosis vaginal en algún momento de la evaluación, siendo el grado 1 el más incidente. De las repercusiones, se identificaron el sufrimiento durante la práctica sexual y la falta de comprensión por parte de la pareja. Conclusión: la estenosis vaginal tiene repercusiones más allá de la fisiología de la mujer, implicando aspectos físicos y emocionales. Por lo tanto, esta investigación aporta ayudas para la toma de decisiones por parte de las enfermeras, los profesionales sanitarios y los gestores para intervenir en las repercusiones de la estenosis vaginal post-braquiterapia ginecológica.

ABSTRACT Objective: to identify the occurrence of vaginal stenosis after gynecologic brachytherapy and its repercussions from the women's perspective. Method: a quantitative-qualitative study, with comparative design with longitudinal section, involving 23 women; and with interpretative design involving seven women, supported by the theoretical referential of culture. Both conducted in a radiotherapy oncology service in southern Brazil. Data collection was performed in 2019, being submitted to descriptive statistics and thematic analysis. Results: it was found that 23 of the participants presented vaginal stenosis at some moment of the evaluation, with grade 1 being the most incident. Of the repercussions, suffering during sexual practice and lack of understanding by the partner were identified. Conclusion: vaginal stenosis has repercussions beyond the woman's physiology, involving physical and emotional aspects. Thus, this research provides subsidies for decision making by nurses, health professionals, and managers to intervene in the repercussions of vaginal stenosis after gynecological radiotherapy.

Mulheres com câncer ginecológico: significado da braquiterapia / Mujeres con cáncerginecológico: significado de la braquiterapia / Women with gynecological cancer: meaning of brachytherapy

RESUMO Objetivo: conhecer o significado da braquiterapia em mulheres com câncer ginecológico. Métodos: pesquisa qualitativa, descritiva e exploratória realizada com 32 mulheres, submetidas à braquiterapia em instituição oncológica de Santa Catarina, Brasil. Na coleta de dados, entre setembro de 2017 e julho de 2018, aplicou-se entrevista semiestruturada. As comunicações foram submetidas à análise de conteúdo, incluindo regras de enumeração para análise dos dados sociodemográficos, clínicos e para quantificação dos relatos agrupados. Publicações relacionadas com o tema e a Teoria do Conforto sustentaram teoricamente a inferência dos dados. Emergiram cinco categorias temáticas, neste artigo apresentam-se três. Resultados: a categoria "O medo e as crenças pessoais no enfrentamento do câncer ginecológico e da braquiterapia" destaca o medo da morte, o desejo pela cura e o apego à família e à religiosidade; "Medo do tratamento e desconfortos relacionados" retrata as alterações relacionadas aos contextos físico, psicológico e ambiental; "Dor como significado" revela a percepção dolorosa sentida pelas mulheres em decorrência da doença ou da braquiterapia. Conclusão: conhecer o significado da braquiterapia permite que os enfermeiros possam repensar a coleta de dados e o planejamento de enfermagem para melhor educação em saúde e redução dos desconfortos.

RESUMEN Objetivo: conocer el significado de la braquiterapia en mujeres con cáncer ginecológico. Métodos: investigación cualitativa, descriptiva y exploratoria realizada con 32 mujeres, sometidas a la braquiterapia en institución oncológica de Santa Catarina, Brasil. En la recolección de datos, entre septiembre de 2017 y julio de 2018, se aplicó entrevista semiestructurada. Los relatos fueron sometidos al análisis de contenido, incluyendo reglas de enumeración para análisis de los datos sociodemográfico, clínicos y para cuantificación de los relatos agrupados. Publicaciones relacionadas con el tema yla Teoría del Confort basaron teóricamente la inferencia de los datos. Surgieron cinco categorías temáticas, en este artículo se presentan tres. Resultados: la categoría "El miedo y las creencias personales en el enfrentamiento del cáncer ginecológico y de la braquiterapia" destaca el temor a la muerte, el deseo por la cura y el apego a la familia y a la religiosidad; "Miedo al tratamiento y las molestias relacionadas" retrata las alteraciones relacionadas a los contextos físico, psicológico y ambiental; "Dolor como significado" revela la percepción dolorosa sentida por las mujeres debido a la enfermedad o la braquiterapia. Conclusión: conocer el significado de la braquiterapia permite que los enfermeros puedan repensar la recolección de datos y la planificación de enfermería para una mejor educación en salud y reducción de las molestias.

ABSTRACT Objective: to know the meaning of brachytherapy in women with gynecological cancer. Methods: qualitative, descriptive and exploratory research conducted with 32 women who underwent brachytherapy at an oncology institution in Santa Catarina, Brazil. Data collection took place between September 2017 and July 2018 through semi-structured interviews. Communications were submitted to content analysis, including enumeration rules for the analysis of sociodemographic and clinical data and for the quantification of grouped reports. Publications related to the theme and the Comfort Theory theoretically supported the inference of the data. Five thematic categories emerged; in this article three are presented. Results: the category "Fear and personal beliefs in coping with gynecological cancer and brachytherapy" highlights the fear of death, the desire for healing and attachment to family and religiosity; "Fear of treatment and related discomforts" depicts changes related to physical, psychological and environmental contexts; "Pain as meaning" reveals the painful perception felt by women as a result of illness or brachytherapy. Conclusion: knowing the meaning of brachytherapy allows nurses to rethink data collection and nursing planning for better health education and reduction of discomfort.

Epidemiological profile of women with gynecological cancer in brachytherapy: a cross-sectional study / Perfil epidemiológico de las mujeres com cáncer ginecológico em brachiterapia: um estúdio transversal / Perfil epidemiológico de mulheres com câncer ginecológico em braquiterapia: estudo transversal

ABSTRACT Objective: to analyze the sociodemographic and clinical profile of women with gynecological cancer in brachytherapy. Method: a cross-sectional study including records of 1,930 visits of women in brachytherapy assisted between 2006-2016 in Santa Catarina (Brazil). Collection was performed in 2019, in an institutional bank, submitted to frequency measurements, chi-square test, 95% confidence intervals, significance level of 0.05. Results: women aged 40-59 years (47.2%), white (93.3%); with elementary school (65%); cervical cancer (78.5%); stages II-III (73.3%) figured prominently. In the comparison of staging proportions in the topography variable, a higher proportion of malignant neoplasm of cervix uteri unspecified in the grouped III-IV staging (84.6%). Conclusion: the profile analysis shows the need for screening and health education for prevention and/or early detection of gynecological cancers and training of nurses specialized in radiotherapy to care for women's health.

RESUMEN Objetivo: analizar el perfil sociodemográfico y clínico de mujeres con cáncer ginecológico en braquiterapia. Método: estudio transversal que incluyó registros de 1.930 visitas de mujeres en braquiterapia asistidas entre 2006-2016 en Santa Catarina (Brasil). La recolección se realizóen 2019, en un banco institucional, sometida a medidas de frecuencia, pruebachi-cuadrado, intervalos de confianza al 95%, nivel de significancia de 0,05. Resultados: predominaron las mujeres entre 40-59 años (47,2%), blancas (93,3%); con educación primaria (65%); cáncer de cuello uterino (78,5%); en estadios II-III (73,3%). Al comparar las proporciones de estadificación en la variable topografía, encontramos una mayor proporción de malignidad cervical no especificada la estadificación agrupada III-IV (84,6%). Conclusión: el análisis del perfil muestra la necesidad de cribado y educación sanitaria para la prevención y/o detección temprana de cánceres ginecológicos y la formación de enfermeras especializadas en radioterapia para el cuidado de la salud de la mujer.

RESUMO Objetivo: analisar o perfil sociodemográfico e clínico de mulheres com câncer ginecológico em braquiterapia. Método: estudo transversal incluindo registros de 1.930 atendimentos de mulheres em braquiterapia assistidas entre 2006-2016 em Santa Catarina (Brasil). Coleta foi realizada em 2019, em banco institucional, submetida às medidas de frequência, Teste Qui-Quadrado, intervalos de 95% de confiança, nível de significância de 0,05. Resultados: predominaram as mulheres entre 40-59 anos (47,2%),brancas (93,3%); com ensino fundamental (65%); câncer do colo do útero (78,5%); nos estádios II-III (73,3%). Na comparação das proporções dos estadiamentos na variável topografia, encontrou-se uma maior proporção da neoplasia maligna do colo do útero não especificada nos estadiamentos III-IV agrupados (84,6%). Conclusão: a análise do perfil mostra a necessidade do rastreamento e educação em saúde para prevenção e/ou detecção precoce dos cânceres ginecológicos e a formação de enfermeiros especialistas em radioterapia para atendimento da saúde da mulher.